SCHEMBL24310683

SCHEMBL24310683

Cc1ccccc1Oc1nc(NSc2cccc(N)c2)nc(-c2ccccc2C(C)C)c1C(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309377 0.94 ADRA2A (0.30) —
SCHEMBL24309360 0.82 DHFR (0.31) DHFR
SCHEMBL24310682 0.80 POLB (0.37) —
SCHEMBL29566908 0.80 POLB (0.37) —
SCHEMBL24309378 0.74 IGF1R (0.30) —
SCHEMBL24309629 0.74 P2RX3 (0.33) DHFR
SCHEMBL24309374 0.73 POLB (0.39) —
SCHEMBL29566992 0.73 POLB (0.39) —
SCHEMBL24309696 0.72 HSP90AA1 (0.35) DHFR
SCHEMBL24310447 0.71 USP1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback